Cargando…

A Pilot Study for the Feasibility of Exome-Sequencing in Circulating Tumor Cells Versus Single Metastatic Biopsies in Breast Cancer

The comparison of the landscape of somatic alterations in circulating tumor cells (CTCs) versus metastases is challenging. Here, we comprehensively characterized the somatic landscape in bulk (amplified and non-amplified), spike-in breast cancer cells, CTCs, and metastases from breast cancer patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaur, Pushpinder, Campo, Daniel, Porras, Tania B., Ring, Alexander, Lu, Janice, Chairez, Yvonne, Su, Yunyun, Kang, Irene, Lang, Julie E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402350/ https://www.ncbi.nlm.nih.gov/pubmed/32650480 http://dx.doi.org/10.3390/ijms21144826

Ejemplares similares

Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer
por: Ring, Alexander, et al.
Publicado: (2022)

Correction to: Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer
por: Ring, Alexander, et al.
Publicado: (2022)

Challenges in using liquid biopsies for gene expression profiling
por: Porras, Tania B., et al.
Publicado: (2018)

Comparison of TCGA and GENIE genomic datasets for the detection of clinically actionable alterations in breast cancer
por: Kaur, Pushpinder, et al.
Publicado: (2019)

EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer
por: Ring, Alexander, et al.
Publicado: (2020)

PIC&RUN: An integrated assay for the detection and retrieval of single viable circulating tumor cells
por: Kamal, Mohamed, et al.
Publicado: (2019)

Author Correction: PIC&RUN: An integrated assay for the detection and retrieval of single viable circulating tumor cells
por: Kamal, Mohamed, et al.
Publicado: (2020)

Analysis of the Whole-Exome Sequencing of Tumor and Circulating Tumor DNA in Metastatic Melanoma
por: Diefenbach, Russell J., et al.
Publicado: (2019)

Whole Exome Analysis to Select Targeted Therapies for Patients with Metastatic Breast Cancer – A Feasibility Study
por: Jaeger, Bernadette Anna Sophia, et al.
Publicado: (2023)

Comparison of whole exome sequencing in circulating tumor cells of primitive and metastatic nasopharyngeal carcinoma
por: Si, Jinyuan, et al.
Publicado: (2020)

Liquid Biopsy Based Circulating Biomarkers in Metastatic Prostate Cancer
por: Dathathri, Eshwari, et al.
Publicado: (2022)

EpCAM based capture detects and recovers circulating tumor cells from all subtypes of breast cancer except claudin-low
por: Ring, Alexander, et al.
Publicado: (2015)

Whole exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer
por: Lohr, Jens G., et al.
Publicado: (2014)

Implementation and use of whole exome sequencing for metastatic solid cancer
por: Réda, Manon, et al.
Publicado: (2020)

Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA
por: Patelli, Giorgio, et al.
Publicado: (2021)

A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix(®) PC1 System
por: Cohen, Evan N., et al.
Publicado: (2022)

Whole-Exome Sequencing to Identify Potential Genetic Risk in Substance Use Disorders: A Pilot Feasibility Study
por: AshaRani, P. V., et al.
Publicado: (2021)

Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?
por: Polasik, Arkadius, et al.
Publicado: (2017)

Liquid biopsy for esophageal cancer: Is detection of circulating cell‐free DNA as a biomarker feasible?
por: Yuan, Zuyang, et al.
Publicado: (2020)

Feasibility of preoperative tattooing of percutaneously biopsied axillary lymph node: an experimental pilot study
por: Sattar, Abida K., et al.
Publicado: (2020)

Exploratory Pilot Study of Circulating Biomarkers in Metastatic Renal Cell Carcinoma
por: Zizzari, Ilaria Grazia, et al.
Publicado: (2020)

Pilot Feasibility Assessment of a Tailored Physical Activity Prescription in Overweight and Obese People in a Public Hospital
por: Tenorio-Mucha, Janeth, et al.
Publicado: (2022)

Whole Exome Sequencing of Multi-Regional Biopsies from Metastatic Lesions to Evaluate Actionable Truncal Mutations Using a Single-Pass Percutaneous Technique
por: Heong, Valerie, et al.
Publicado: (2020)

Circulating long non-coding RNA EWSAT1 acts as a liquid biopsy marker for esophageal squamous cell carcinoma: A pilot study
por: Uttam, Vivek, et al.
Publicado: (2023)

Rare Variants in Ischemic Stroke: An Exome Pilot Study
por: Cole, John W., et al.
Publicado: (2012)

Pilot Study of Circulating Tumor Cells in Early-Stage and Metastatic Uveal Melanoma
por: Anand, Kartik, et al.
Publicado: (2019)

Utility of exome sequencing in routine care for metastatic colorectal cancer
por: D'Agay, Melchior De Giraud, et al.
Publicado: (2021)

Metastatic Disease to Clivus: Biopsy or Not?
por: Cathel, Alessandra, et al.
Publicado: (2019)

Fugitives on the run: circulating tumor cells (CTCs) in metastatic diseases
por: Mamdouhi, Tania, et al.
Publicado: (2019)

Defining A Liquid Biopsy Profile of Circulating Tumor Cells and Oncosomes in Metastatic Colorectal Cancer for Clinical Utility
por: Narayan, Sachin, et al.
Publicado: (2022)

Exploration of Circulating Tumour Cell (CTC) Biology: A Paradigm Shift in Liquid Biopsy
por: Chauhan, Anshika, et al.
Publicado: (2020)

Physical activity in older adults with metastatic gastrointestinal cancer: a pilot and feasibility study
por: Brown, Justin C, et al.
Publicado: (2022)

Whole Exome Sequencing Among 26 Patients With Indeterminate Acute Liver Failure: A Pilot Study
por: Rakela, Jorge, et al.
Publicado: (2019)

Whole Exome Sequencing of a Patient with Metastatic Hidradenocarcinoma and Review of the Literature
por: Gupta, Eva, et al.
Publicado: (2015)

Whole-Exome Sequencing of Matched Primary and Metastatic Papillary Thyroid Cancer
por: Masoodi, Tariq, et al.
Publicado: (2020)

Evaluation of Storage Tubes for Combined Analysis of Circulating Nucleic Acids in Liquid Biopsies
por: Ward Gahlawat, Aoife, et al.
Publicado: (2019)

Low Input Whole-Exome Sequencing to Determine the Representation of the Tumor Exome in Circulating DNA of Non-Small Cell Lung Cancer Patients
por: Dietz, Steffen, et al.
Publicado: (2016)

Circulating Long Non-Coding RNAs LINC00324 and LOC100507053 as Potential Liquid Biopsy Markers for Esophageal Squamous Cell Carcinoma: A Pilot Study
por: Sharma, Uttam, et al.
Publicado: (2022)

Efficacy of platinum-based chemotherapy in metastatic breast cancer and HRD biomarkers: utility of exome sequencing
por: Galland, Loïck, et al.
Publicado: (2022)

Androgen receptor amplification is concordant between circulating tumor cells and biopsies from men undergoing treatment for metastatic castration resistant prostate cancer
por: Podolak, Jennifer, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6v2h5p2tocpqb1ao9fch8mms51